Novel agents for sexual dysfunction.
Hopps, C V
Novel agents for sexual dysfunction. [electronic resource] - BJU international Oct 2003 - 534-8 p. digital
Publication Type: Journal Article; Review
1464-4096
10.1046/j.1464-410x.2003.04425.x doi
Administration, Topical
Adrenergic alpha-Antagonists--therapeutic use
Alprostadil--administration & dosage
Amides--therapeutic use
Calcium Channels--physiology
Dopamine Agonists--therapeutic use
Drug Therapy, Combination
Endothelial Growth Factors--therapeutic use
Enzyme Inhibitors--therapeutic use
Erectile Dysfunction--drug therapy
Humans
Intercellular Signaling Peptides and Proteins--therapeutic use
Lymphokines--therapeutic use
Male
Nitric Oxide Synthase--therapeutic use
Phosphodiesterase Inhibitors--therapeutic use
Pyridines--therapeutic use
Receptors, Corticotropin--antagonists & inhibitors
Receptors, Melanocortin
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors
Novel agents for sexual dysfunction. [electronic resource] - BJU international Oct 2003 - 534-8 p. digital
Publication Type: Journal Article; Review
1464-4096
10.1046/j.1464-410x.2003.04425.x doi
Administration, Topical
Adrenergic alpha-Antagonists--therapeutic use
Alprostadil--administration & dosage
Amides--therapeutic use
Calcium Channels--physiology
Dopamine Agonists--therapeutic use
Drug Therapy, Combination
Endothelial Growth Factors--therapeutic use
Enzyme Inhibitors--therapeutic use
Erectile Dysfunction--drug therapy
Humans
Intercellular Signaling Peptides and Proteins--therapeutic use
Lymphokines--therapeutic use
Male
Nitric Oxide Synthase--therapeutic use
Phosphodiesterase Inhibitors--therapeutic use
Pyridines--therapeutic use
Receptors, Corticotropin--antagonists & inhibitors
Receptors, Melanocortin
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors